Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
2017 Startups to Watch
stats here
Related Posts on Startland News
Main Street is already harnessing AI to build wealth; adoption now key to region’s growth, heartland leaders say
WICHITA, Kan. — Artificial intelligence is likely to be one of the most transformative technologies of the digital era, said Taylor Eubanks, noting that AI’s thoughtful deployment can be a tool for growth, not displacement. “By engaging directly with entrepreneurs, small businesses, nonprofit leaders and local innovators, we can better support responsible AI adoption that…
AlphaGraphics expansion boasts $1.4M investment, plans to create 16 new KC jobs
A production crew known for eye-catching, colorful designs splashed across Kansas City — including its own East Crossroads headquarters — is expanding its physical and human footprint, marking a key investment in the metro’s growing creative and professional services sector, local leaders said. AlphaGraphics on Tuesday announced an investment of more than $1.4 million and…
Arch Grants taps homegrown founders, Missouri startup recruits for $1.6M in awards
ST. LOUIS — The Missouri maker behind a keychain designed to save lives from opioid overdoses is among nearly two dozen companies — together awarded $1.6 million — selected for the latest Arch Grants program. The innovation economy nonprofit on Thursday honored 19 startups, alongside three new members of its expanded Arch Grants Fellows Program.…
LISTEN: Gripp helps farmers get a handle on multiple ag apps with dead-simple record keeping platform
On this episode of our 12-part Plug and Play Topeka podcast series, we explore how agtech startup Gripp is bringing structure and simplicity to farm operations. Its helps farmers connect their teams, track equipment and assets, and turn everyday routines into shared knowledge. Having grown up on a Wisconsin farm, co-founder and CEO Tracey Wiedmeyer…